<<<I would submit that your views have been colored by spending too much time on InvestorVillage.>>>
Dew, I am amazed that you find nothing wrong with the blatant statement, leaving out all that material information about safety issues and duration of efficacy, and that the drug appears to work well only in very early stage MS, that campath is more effective and safer than tysabri.
That is not a statement that you find objectionable both scientifically, ethically, and as a marketing message that I'm sure if the FDA cared they would find it an illegal marketing statement as well?
In regard to the Schering article that we discussed about 6 months ago regarding telaprevir quoting the "intern" you found that a valid and reliable source in regard to how desperate and dangerous telaprevir was in comparison to Schering's drug?
I guess I might as well just leave my political reading to the Daily Kos, or just to the Wall Street Journal. No sense trying to get the objective truth on the matter if that is the case.
Tinker
Market Data 
Markets 
AI
